| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-A02303741:carboplatin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.012 | 0.8 |
| mRNA | ETP-46464 | CTRPv2 | pan-cancer | AAC | 0.013 | 0.8 |
| mRNA | ruxolitinib | GDSC1000 | pan-cancer | AAC | -0.01 | 0.8 |
| mRNA | MI-1 | CTRPv2 | pan-cancer | AAC | 0.012 | 0.8 |
| mRNA | LY317615 | GDSC1000 | pan-cancer | AAC | -0.01 | 0.8 |
| mRNA | ML258 | CTRPv2 | pan-cancer | AAC | -0.011 | 0.8 |
| mRNA | PHA-665752 | CCLE | pan-cancer | AAC | 0.014 | 0.8 |
| mRNA | RAF265 | CTRPv2 | pan-cancer | AAC | -0.012 | 0.8 |
| mRNA | dexamethasone | CTRPv2 | pan-cancer | AAC | -0.0097 | 0.8 |
| mRNA | Nutlin-3a (-) | GDSC1000 | pan-cancer | AAC | -0.0097 | 0.8 |